To assess the role of HMGB2 expression in CD8+ T cells on tumor control, we adoptively transferred 1 × 106 congenically marked WT or Hmgb2−/− P14 T cells into separate, congenically mismatched WT mice. The gene discussed is CD8A; the disease is neoplasm.